These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14597237)

  • 1. The role of the matrix metalloproteinases in human endometrial and ovarian cycles.
    Goldman S; Shalev E
    Eur J Obstet Gynecol Reprod Biol; 2003 Dec; 111(2):109-21. PubMed ID: 14597237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
    Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
    Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of metalloproteinases in endometrial remodelling during menstrual cycle.
    Grzechocińska B; Dąbrowski F; Cyganek A; Panek G; Wielgoś M
    Ginekol Pol; 2017; 88(6):337-342. PubMed ID: 28727135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo.
    Vassilev V; Pretto CM; Cornet PB; Delvaux D; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5848-57. PubMed ID: 16046583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle.
    Curry TE; Osteen KG
    Endocr Rev; 2003 Aug; 24(4):428-65. PubMed ID: 12920150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
    Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
    J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
    Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating ovarian steroids and endometrial matrix metalloproteinases (MMPs).
    Henriet P; Cornet PB; Lemoine P; Galant C; Singer CF; Courtoy PJ; Eeckhout Y; Marbaix E
    Ann N Y Acad Sci; 2002 Mar; 955():119-38; discussion 157-8, 396-406. PubMed ID: 11949942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
    Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
    Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus.
    Curry TE; Osteen KG
    Biol Reprod; 2001 May; 64(5):1285-96. PubMed ID: 11319131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
    Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
    Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation.
    Zhang J; Salamonsen LA
    J Clin Endocrinol Metab; 2002 May; 87(5):2346-51. PubMed ID: 11994386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles.
    Hrabia A; Socha JK; Sechman A
    Gen Comp Endocrinol; 2018 May; 260():32-40. PubMed ID: 29438675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone action in the human endometrium: induction of a unique tissue environment which limits matrix metalloproteinase (MMP) expression.
    Osteen KG; Igarashi TM; Bruner-Tran KL
    Front Biosci; 2003 Jan; 8():d78-86. PubMed ID: 12456342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role and regulation of the uterine matrix metalloproteinase system in menstruating and non-menstruating species.
    Zhang X; Nothnick WB
    Front Biosci; 2005 Jan; 10():353-66. PubMed ID: 15574374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium.
    Freitas S; Meduri G; Le Nestour E; Bausero P; Perrot-Applanat M
    Biol Reprod; 1999 Oct; 61(4):1070-82. PubMed ID: 10491646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal expression profile of matrix metalloproteinase (Mmp) modulators Reck and Sparc during the rat ovarian dynamics.
    Levin G; Coelho TM; Nóbrega NG; Trombetta-Lima M; Sogayar MC; Carreira ACO
    Reprod Biol Endocrinol; 2018 Nov; 16(1):116. PubMed ID: 30424792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of LEFTY-A/EBAF in the human endometrium. mRNA expression during the menstrual cycle, control by progesterone, and effect on matrix metalloprotineases.
    Cornet PB; Picquet C; Lemoine P; Osteen KG; Bruner-Tran KL; Tabibzadeh S; Courtoy PJ; Eeckhout Y; Marbaix E; Henriet P
    J Biol Chem; 2002 Nov; 277(45):42496-504. PubMed ID: 12215426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
    Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
    Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels.
    Shaaban MM; Segal S; Salem HT; Ghaneimah SA; Khalifa EA; Ahmed AG
    Fertil Steril; 1993 May; 59(5):998-1002. PubMed ID: 8486202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.